HIV and Hepatitis C Among People Who Inject Drugs in Memphis, Tennessee: an Intersectional Risk Environment Analysis of the Social Determinants of Health

被引:0
作者
Flath, Natalie [1 ]
Marr, Jack H. [2 ]
Sizemore, Lindsey [3 ]
Pichon, Latrice C. [4 ]
Brantley, Meredith [5 ]
机构
[1] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway, Baltimore, MD 21205 USA
[2] Tennessee Dept Hlth, Communicable & Environm Dis & Emergency Preparedn, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[3] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[4] Univ Memphis, Sch Publ Hlth, Div Social & Behav Sci, 209 Robison Hall, Memphis, TN 38152 USA
[5] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
关键词
HIV; HCV; Persons who inject drugs; Social determinants of health; Intersectional public health; OPIOID CRISIS; UNITED-STATES; B-VIRUS; BALTIMORE; INFECTION; VULNERABILITY; POPULATIONS; DISPARITIES; IMPACT; AIDS;
D O I
10.1007/s40615-023-01878-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe Southern US is confronting bourgeoning HIV and hepatitis C virus (HCV) epidemics among people who inject drugs (PWID), yet little is known about shared and unique risk factors across the region. We applied an intersectional risk environment framework to understand infectious disease outcomes for sub-groups of PWID that experience multiple axes of social marginalization related to racial and ethnic identity and social and economic vulnerability.MethodsHIV and HCV prevalence was estimated from the first iteration of the CDC's National HIV Behavioral Surveillance respondent driven sample of PWID in Shelby County, Tennessee in 2018. We ran adjusted multinomial models to test main and interaction effects of race/ethnicity and structural factors on the prevalence of a three-level outcome: HIV-only, HCV-only, and no infection.ResultsA total of 564 PWID participated, 558 (99%) completed HIV testing, and 540 (96%) HCV testing. Thirty (5%) were HIV-positive, 224 (40%) HCV-positive, and less than 1% were co-infected. Descriptive differences by race/ethnicity and levels of structural vulnerability for HIV and HCV subpopulations were present; however, there was no evidence for statistical interaction. In the final main effects model, HIV status was positively associated with non-Hispanic Black identity (aRR 4.95, 95% CI 1.19, 20.6), whereas HCV status was associated with non-white identity (aRR 0.11 95% CI 0.07, 0.18). Factors associated with HCV infection were higher scores of structural vulnerability (aRR 2.19 95% CI 1.10, 4.35), and criminal legal involvement (aOR 1.99 95% CI 1.18, 3.37).ConclusionThis is the first study to implement local population-based survey data to evaluate distinctive intersections of ethnic/racial and social factors associated with HIV and HCV status among PWID in the Memphis region. Findings come at an opportune time as harm reduction programs are in development in the South and shed light to the need for socially equitable race conscious resource investment.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 50 条
  • [41] Gender differences in planning ability and hepatitis C virus among people who inject drugs
    Scheidell, J. D.
    Khan, M. R.
    Clifford, L. M.
    Dunne, E. M.
    Keen, L. D., II
    Latimer, W. W.
    ADDICTIVE BEHAVIORS, 2015, 47 : 33 - 37
  • [42] HIV and viral hepatitis C coinfection in people who inject drugs: implications of new direct acting antivirals for hepatitis C virus treatment
    Walsh, Nick
    Maher, Lisa
    CURRENT OPINION IN HIV AND AIDS, 2012, 7 (04) : 339 - 344
  • [43] Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine
    Iakunchykova, Olena
    Meteliuk, Anna
    Zelenev, Alexei
    Mazhnaya, Alyona
    Tracy, Melissa
    Altice, Frederick L.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 57 : 11 - 17
  • [44] Can hepatitis C elimination targets be sustained among people who inject drugs post-2030?
    Delaunay, Charlotte Laniece
    Godin, Arnaud
    Kronfli, Nadine
    Panagiotoglou, Dimitra
    Cox, Joseph
    Alary, Michel
    Klein, Marina B.
    Maheu-Giroux, Mathieu
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 96
  • [45] The status of hepatitis C virus infection among people who inject drugs in the Middle East and North Africa
    Mahmud, Sarwat
    Mumtaz, Ghina R.
    Chemaitelly, Hiam
    Al Kanaani, Zaina
    Kouyoumjian, Silva P.
    Hermez, Joumana G.
    Abu-Raddad, Laith J.
    ADDICTION, 2020, 115 (07) : 1244 - 1262
  • [46] Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California
    Ozga, Jenny E.
    Syvertsen, Jennifer L.
    Pollini, Robin A.
    JOURNAL OF VIRAL HEPATITIS, 2022, 29 (07) : 518 - 528
  • [47] Policing Practices and Risk of HIV Infection Among People Who Inject Drugs
    Baker, Pieter
    Beletsky, Leo
    Avalos, Liliana
    Venegas, Christopher
    Rivera, Carlos
    Strathdee, Steffanie A.
    Cepeda, Javier
    EPIDEMIOLOGIC REVIEWS, 2020, 42 (01) : 27 - 40
  • [48] HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya
    Kurth, Ann E.
    Cleland, Charles M.
    Des Jarlais, Don C.
    Musyoki, Helgar
    Lizcano, John A.
    Chhun, Nok
    Cherutich, Peter
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (04) : 420 - 427
  • [49] Prevalence and associated risk factors of hepatitis C antibody and RNA among people who inject drugs in Puerto Rico
    Aponte-Melendez, Yesenia
    Eckhardt, Benjamin
    Fong, Chunki
    Padilla, Adriana
    Trinidad-Martinez, Wanda
    Maldonado-Rodriguez, Eric
    Agront, Nancy
    Mateu-Gelabert, Pedro
    JOURNAL OF SUBSTANCE USE & ADDICTION TREATMENT, 2024, 160
  • [50] Sex work and HIV incidence among people who inject drugs
    Kerr, Thomas
    Shannon, Kate
    Ti, Lianping
    Strathdee, Steffanie
    Hayashi, Kanna
    Paul Nguyen
    Montaner, Julio
    Wood, Evan
    AIDS, 2016, 30 (04) : 627 - 634